159886-35-8

Basic information

• Product Name: 2-[4-(3-Bromopropylcarbamoyl)-5-(trifluoromethyl)pyrazol-1-yl]-4-(3-trifluoromethylphenyl)thiazole
• Synonyms: 2-[4-(3-Bromopropylcarbamoyl)-5-(trifluoromethyl)pyrazol-1-yl]-4-(3-trifluoromethylphenyl)thiazole
• CAS NO: 159886-35-8
• Molecular Weight: 527.288
• Mol File: 159886-35-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-[4-(3-Bromopropylcarbamoyl)-5-(trifluoromethyl)pyrazol-1-yl]-4-(3-trifluoromethylphenyl)thiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[4-(3-Bromopropylcarbamoyl)-5-(trifluoromethyl)pyrazol-1-yl]-4-(3-trifluoromethylphenyl)thiazole(159886-35-8)
• EPA Substance Registry System: 2-[4-(3-Bromopropylcarbamoyl)-5-(trifluoromethyl)pyrazol-1-yl]-4-(3-trifluoromethylphenyl)thiazole(159886-35-8)

Safety Data

• Hazardous Substances Data: 159886-35-8(Hazardous Substances Data)

Upstream product

• 5003-71-4 3-bromopropylamine hydrochloride 
• 159885-79-7 2-<4-carboxy-5-(trifluoromethyl)pyrazol-1-yl>-4-<3-(trifluoromethyl)phenyl>thiazole 
• 159885-60-6 2-<4-carboethoxy-5-(trifluoromethyl)pyrazol-1-yl>-4-<3-(trifluoromethyl)phenyl>thiazole 
• 2003-10-3 2-bromo-1-[3-(trifluoromethyl)phenyl]ethanone 
• 349-76-8 3'-(trifluoromethyl)acetophenone 
• 1048670-08-1 2-[1-ethoxy-meth-(Z)-ylidene]-4,4,4-trifluoro-3-oxo-butyric acid ethyl ester 

Downstream Products

• 1026813-13-7 5-Trifluoromethyl-1-[4-(3-trifluoromethyl-phenyl)-thiazol-2-yl]-1H-pyrazole-4-carboxylic acid (4-imino-butyl)-amide 
• 1026655-81-1 5-Trifluoromethyl-1-[4-(3-trifluoromethyl-phenyl)-thiazol-2-yl]-1H-pyrazole-4-carboxylic acid (3-cyano-propyl)-amide 
• 1025873-47-5 5-Trifluoromethyl-1-[4-(3-trifluoromethyl-phenyl)-thiazol-2-yl]-1H-pyrazole-4-carboxylic acid (3-azido-propyl)-amide 

Relevant articles and documents

Novel thiazole-based heterocycles as selective inhibitors of fibrinogen- mediated platelet aggregation

The synthesis and biological activity of novel thiazole-based heterocycles as inhibitors of thrombin-induced human platelet aggregation are described. Further evaluation of selected compounds show they inhibit platelet aggregation as stimulated by a varie